The aim of this article is to quantitatively assess the efficacy of different upper limb interventions on healthrelated quality of life (QOL) in stroke patients.Method:
Two botulinum type A injection (BTX-A) studies and 4 constraintinduced movement therapy (CIMT) studies were separately combined in a meta-analysis using a fixed effects model. QOL mean scores were extracted and transformed into weighted mean differences.Results:
Combined, the BTX-A studies showed no significant improvements in overall health-related QOL. Similarly, a meta-analysis of 4 CIMT studies revealed nonsignificant findings for the domains of activities of daily living, communication, and hand function. A separate meta-analysis of 3 CIMT studies showed a significant increase in strength scores (P = .007); however, sensitivity analysis for this domain due to significant heterogeneity led to a new P value of .078, showing a nonsignificant increase in strength. Further results for memory, mobility, mood, participation, and overall recovery were all nonsignificant.Conclusion:
This report did not show these types of upper limb interventions to be effective in improving health-related QOL in the poststroke population.